Search results
Taro Shareholders Approve Merger with Sun Pharma
KTLA-TV Los Angeles· 6 days agoSun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) (together with its subsidiaries and/or associates referred as "Sun ...
Merck to Buy Eye Drug Company Eyebiotech for Up to $3 Billion. It’s Doubling Down on Deals.
Barrons.com· 9 hours agoThe pharmaceutical company agrees to buy eye drug company Eyebiotech for up to $3 billion as it...
US Bancorp DE Has $4.34 Million Stock Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
ETF DAILY NEWS· 12 hours agoUS Bancorp DE grew its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 6.7% in the 4th quarter, according to the company in its most recent ...
Over-Counter Birth Control Pill Maker Brings Back Ex-Law Head
Bloomberg Law· 5 hours ago, a pharmaceutical company that in March began offering the first over-the-counter oral birth control pill in the US, is bringing back its former top lawyer Todd Kingma. Kingma ...
JD Supra: EU and UK Consider First Stand-Alone Disparagement Cases
JD Supra· 3 hours agoThe development of case law on disparagement has, to date, been driven mainly by the French competition authority, or has been addressed under consumer protection or other national laws. The ...
Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know
Zacks via Yahoo Finance· 9 hours agoShares of this world's biggest maker of health care products have returned -0.2% over the past month...
Milestone Pharma's NDA For Cardamyst Spray Gets FDA Acceptance, Shares Up
RTT News· 10 hours agoMilestone Pharmaceuticals Inc. (MIST) Wednesday announced that the FDA has accepted the Company's New Drug Application or NDA for Cardamyst nasal spray to manage paroxysmal supraventricular tachycardia or PSVT.
JPMorgan maintains Overweight rating on Biohaven stock By Investing.com
Investing.com· 4 hours agoOn Wednesday, JPMorgan reaffirmed its Overweight rating and $55.00 price target for Biohaven ...
Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Docetaxel Injection, USP Due to...
WPRI Providence· 22 hours agoSagent Pharmaceuticals today announced the voluntary nationwide recall of two lots of Docetaxel Injection, USP (80 mg per 8 mL multi-dose vials and 160 mg per 16 mL multi-dose ...
Merck introduces sterility testing solution for pharma quality control
Pharmaceutical Technology via Yahoo Finance· 13 hours agoThe offering aims to enhance process safety by automatically documenting each step of the testing...